These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 3092344)
21. The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome. McLean AJ; Harrison PM; Ioannides-Demos L; Byrne AJ; McCarthy P; Dudley FJ Aust N Z J Med; 1985 Jun; 15(3):367-74. PubMed ID: 3904700 [TBL] [Abstract][Full Text] [Related]
22. Role of aggressive factors in the pathogenesis of peptic ulcer disease. Richardson CT Scand J Gastroenterol Suppl; 1990; 174():37-43. PubMed ID: 2119515 [TBL] [Abstract][Full Text] [Related]
23. Relationship between inhibition of acid secretion and healing of peptic ulcers. Chiverton SG; Hunt RH Scand J Gastroenterol Suppl; 1989; 166():43-7; discussion 74-5. PubMed ID: 2690331 [TBL] [Abstract][Full Text] [Related]
24. Aetiology of peptic ulcer. Lam SK Ann Acad Med Singap; 1983 Oct; 12(4):498-506. PubMed ID: 6378055 [TBL] [Abstract][Full Text] [Related]
25. Is it really more difficult to treat prepyloric ulcers? Halter F; Eigenmann F Aliment Pharmacol Ther; 1987; 1 Suppl 1():433S-438S. PubMed ID: 2979694 [TBL] [Abstract][Full Text] [Related]
26. Prepyloric erosions and related changes. Berstad A; Nesland A Scand J Gastroenterol; 1985 Sep; 20(7):779-82. PubMed ID: 3901234 [No Abstract] [Full Text] [Related]
27. Results of short- and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion. Ström M; Berstad A; Bodemar G; Walan A Scand J Gastroenterol; 1986 Jun; 21(5):521-30. PubMed ID: 3092344 [TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of roxatidine acetate: a review. Dammann HG; de Looze SM; Bender W; Labs R Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer. de Bruijne JW; Snel P; Lamers CB Digestion; 1989; 44 Suppl 1():25-30. PubMed ID: 2691308 [TBL] [Abstract][Full Text] [Related]
30. Cimetidine. I. Developments, pharmacology, and efficacy. Freston JW Ann Intern Med; 1982 Oct; 97(4):573-80. PubMed ID: 6751184 [TBL] [Abstract][Full Text] [Related]
31. The therapeutic efficacy of misoprostol in peptic ulcer disease. Watkinson G; Hopkins A; Akbar FA Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682 [TBL] [Abstract][Full Text] [Related]
32. Medical therapy of peptic ulcer disease. McQuaid KR; Isenberg JI Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960 [TBL] [Abstract][Full Text] [Related]